Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China

Stroke

Volumn 46, Issue 10, 2015, Pages 2822-2829

  Miao, Zhongrong ^a   Zhang, Yong ^b   Shuai, Jie ^c   Jiang, Changchun ^d   Zhu, Qiyi ^e   Chen, Kangning ^c   Liu, Li ^f   Li, Baomin ^g   Shi, Xiangqun ^h   Gao, Lianbo ⁱ   Liu, Yajie ^j   Wang, Feng ^k   Li, Yongli ^l   Liu, Tieyan ^m   Zheng, Hongbo ⁿ   Wang, Yilong ^a   Wang, Yongjun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d Baotou   (China)

^e LINYI PEOPLE'S HOSPITAL   (China)

^f Department of Neurology Hospital of Chifeng City   (China)

^g CHINESE PLA GENERAL HOSPITAL   (China)

^h LANZHOU GENERAL HOSPITAL   (China)

ⁱ CHINA MEDICAL UNIVERSITY   (China)

^j SOUTHERN MEDICAL UNIVERSITY   (China)

^k DALIAN MEDICAL UNIVERSITY   (China)

^l HARBIN MEDICAL UNIVERSITY   (China)

^m CANGZHOU CENTRAL HOSPITAL   (China)

ⁿ SICHUAN UNIVERSITY   (China)

more..

Author keywords

Atherosclerosis; Ischemic attack, transient; Middle cerebral artery; Stroke; Vertebral artery

Indexed keywords

ADULT; ANGINA PECTORIS; ARTICLE; BALLOON MOUNTED STENT; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CHINA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; GROIN HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORI A LESION; MORI C LESION; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF EXPANDING STENT; STOMACH HEMORRHAGE; SYMPTOMATIC INTRACRANIAL ARTERY STENOSIS; TRANSIENT ISCHEMIC ATTACK; UPPER RESPIRATORY TRACT INFECTION; VASCULAR STENT; VERTEBRAL ARTERY STENOSIS; CLINICAL TRIAL; DEVICES; ENDOVASCULAR SURGERY; INTRACRANIAL ARTERIOSCLEROSIS; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; REGISTER; STENT;

CHINA; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; REGISTRIES; STENTS;

EID: 84942859369     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.010549     Document Type: Article

References (27)

1. Redon J, Olsen MH, Cooper RS, Zurriaga O, Martinez-Beneito MA, Laurent S, et al. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J. 2011;32:1424-1431. doi: 10.1093/eurheartj/ehr045.
2. Wong KS, Li H, Lam WW, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke. 2002;33:532-536.
3. Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, et al; NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70:1518-1524. doi: 10.1212/01.wnl.0000306308.08229.a3.
4. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993-1003. doi: 10.1056/NEJMoa1105335.
5. Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, et al; VISSIT Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313:1240-1248. doi: 10.1001/jama.2015.1693.
6. Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12:1106-1114. doi: 10.1016/S1474-4422(13)70195-9.
7. López-Cancio E, Matheus MG, Romano JG, Liebeskind DS, Prabhakaran S, Turan TN, et al. Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2014;37:417-422. doi: 10.1159/000362922.
8. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol. 1998;19:1525-1533.
9. Ding D, Starke RM, Crowley RW, Liu KC. Role of stenting for intracranial atherosclerosis in the post-SAMMPRIS era. Biomed Res Int. 2013;2013:304320. doi: 10.1155/2013/304320.
10. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, et al; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the fnal results of a randomised trial. Lancet. 2014;383:333-341. doi: 10.1016/S0140-6736(13)62038-3.
11. Suri MF, Johnston SC. Epidemiology of intracranial stenosis. J Neuroimaging. 2009;19(suppl 1):11S-16S. doi: 10.1111/j.1552-6569.2009.00415.x.
12. Ssi-Yan-Kai G, Nasr N, Faury A, Catalaa I, Cognard C, Larrue V, et al. Intracranial artery stenosis or occlusion predicts ischemic recurrence after transient ischemic attack. AJNR Am J Neuroradiol. 2013;34:185-190. doi: 10.3174/ajnr.A3144.
13. Niu JW, Gao S, Cui LY, Peng B, Zhu YC, Ni J, et al. Intracranial atherosclerosis in Chinese young adult stroke patients. J Stroke Cerebrovasc Dis. 2014;23:1519-1523. doi: 10.1016/j. jstrokecerebrovasdis.2013.12.030.
14. Jiang WJ, Yu W, Du B, Gao F, Cui LY. Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting. Stroke. 2011;42:1971-1975. doi: 10.1161/STROKEAHA.110.595926.
15. Jiang WJ, Xu XT, Jin M, Du B, Dong KH, Dai JP. Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol. 2007;28:830-834.
16. Miao Z, Song L, Liebeskind DS, Liu L, Ma N, Wang Y, et al. Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS. J Neurointerv Surg. 2015;7:331-335. doi: 10.1136/neurintsurg-2014-011109.
17. Miao Z. Intracranial angioplasty and stenting before and after SAMMPRIS: "From Simple to Complex Strategy-The Chinese Experience." Front Neurol. 2014;5:129. doi: 10.3389/fneur.2014.00129.
18. Wang Y, Miao Z, Wang Y, Zhao X, Gao P, Liu L, et al; China Registry Study Group. Protocol for a prospective, multicentre registry study of stenting for symptomatic intracranial artery stenosis in China. BMJ Open. 2014;4:e005175. doi: 10.1136/bmjopen-2014-005175.
19. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643-646.
20. Higashida R, Furlan A, Roberts H, Tomsick T, Connors B, Barr J, et al; Technology Assessment Committees of the American Society of Interventional and Therapeutic Neuroradiology and the Society of Interventional Radiology. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol. 2003;14(9 pt 2):S493-S494.
21. Shuaib A, Butcher K, Mohammad AA, Saqqur M, Liebeskind DS. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol. 2011;10:909-921. doi: 10.1016/S1474-4422(11)70195-8.
22. Abe A, Ueda T, Ueda M, Nogoshi S, Nishiyama Y, Katayama Y. Symptomatic middle cerebral artery stenosis treated by percutaneous transluminal angioplasty: improvement of cerebrovascular reserves. Interv Neuroradiol. 2012;18:213-220.
23. Derdeyn C P, Fiorella D, Lynn MJ, Rumboldt Z, Cloft HJ, Gibson D, et al; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013;72:777-795, discussion 795. doi: 10.1227/NEU.0b013e318286fdc8.
24. Nair PK, Mulukutla SR, Marroquin OC. Stents and statins: history, clinical outcomes and mechanisms. Expert Rev Cardiovasc Ther. 2010;8:1283-1295. doi: 10.1586/erc.10.113.
25. Perler BA. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting. Semin Vasc Surg. 2007;20:252-258. doi: 10.1053/j. semvascsurg.2007.10.008.
26. Verzini F, De Rango P, Parlani G, Giordano G, Caso V, Cieri E, et al. Effects of statins on early and late results of carotid stenting. J Vasc Surg. 2011;53:71-79, discussion 79. doi: 10.1016/j.jvs.2010.08.024.
27. Pieniazek P, Tekieli L, Musiałek P, Kabłak Ziembicka A, Przewłocki T, Motyl R, et al. Carotid artery stenting according to the tailored-CAS algorithm is associated with a low complication rate at 30 days: data from the TARGET-CAS study. Kardiol Pol. 2012;70:378-386.